ID
PFE icon

Integral Derivatives’s Pfizer PFE Stock Holding History

Integral Derivatives’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$522K Sell
15,494
-57,759
-79% -$1.99M 0.01% 378
2017
Q4 		$2.52M Buy
73,253
+18,234
+33% +$622K 0.05% 235
2017
Q3 		$1.86M Sell
55,019
-22,555
-29% -$725K 0.03% 331
2017
Q2 		$2.47M Sell
77,574
-22,767
-23% -$718K 0.05% 257
2017
Q1 		$3.26M Buy
100,341
+6,113
+6% +$193K 0.06% 207
2016
Q4 		$2.9M Buy
94,228
+50,065
+113% +$1.53M 0.05% 228
2016
Q3 		$1.42M Sell
44,163
-21,290
-33% -$712K 0.03% 352
2016
Q2 		$2.19M Buy
+65,453
New +$2.09M 0.05% 221
2016
Q1 		– Sell
-47,430
Closed -$1.45M – 1049
2015
Q4 		$1.45M Buy
47,430
+35,731
+305% +$1.12M 0.04% 352
2015
Q3 		$349K Buy
+11,699
New +$375K 0.01% 812
2015
Q1 		– Sell
-28,985
Closed -$857K – 1327
2014
Q4 		$857K Sell
28,985
-5,270
-15% -$151K 0.01% 724
2014
Q3 		$961K Sell
34,255
-51,224
-60% -$1.44M 0.02% 730
2014
Q2 		$2.41M Buy
85,479
+76,520
+854% +$2.18M 0.04% 353
2014
Q1 		$273K Sell
8,959
-30,039
-77% -$896K 0.01% 1090
2013
Q4 		$1.13M Buy
+38,998
New +$1.13M 0.02% 736

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Integral Derivatives's PFE Position: Q4 2017 in Review

Integral Derivatives sold out of Pfizer (PFE) in Q4 2017, closing a stake of 34,299 shares — an estimated $1.17M sold.

Integral Derivatives first reported a position in PFE in Q1 2014 and held it in 9 quarters. The position peaked at $1.59M in Q2 2017. 2,243 funds tracked by Wall St. Rank hold PFE as of Q4 2017.

  • Integral Derivatives reported no remaining Pfizer position as of Q4 2017 after selling out during the quarter.
  • Integral Derivatives sold 34,299 Pfizer shares in Q4 2017, an estimated $1.17M.
  • Integral Derivatives first reported a position in Pfizer in Q1 2014 and held it in 9 quarters.
  • Integral Derivatives's Pfizer position peaked at $1.59M in Q2 2017.
  • 2,243 funds tracked by Wall St. Rank held Pfizer as of Q4 2017.

Based on Integral Derivatives's 13F filing for Q4 2017, filed 14 Feb 2018.